Medico-legal Assessment of Sexual Violence-Assiut University

June 19, 2022 updated by: Ahmed Mohamed Ahmed Othman, Assiut University

Medico-legal Assessment of Sexual Violence and Pregnancy Related Allegations Among Females Presented to Women's Health Hospital -Assiut University

  • Medico legal assessment of sexual assaults allegations of females presented to hospital and any associated violence.
  • Assessment of cases of pregnancy associated violence with other related complications that have both medical and legal implications.
  • Knowing role of VAW Unit in compacting female abuse offering support and authentication of suspicious claims

Study Overview

Status

Not yet recruiting

Intervention / Treatment

Detailed Description

The data will be obtained after informed consents from cases. These cases will be then analyzed in terms of:

  • Verifying legal procedures as careful reviewing of public prosecution order and associated victim's identification documents if present
  • Obtain a detailed history including personal information as age, marital status' residence and education; incident circumstances like assault characteristics as numbers of assailants, relationship to the victim' place of assault' frequency of assault and the time lapse between examination and last assault, etc ; gynecologic and obstetric history.
  • General examination that include proper documentation of all visible injuries all over the body (type' direction' location' shape) and local examination of genital or anal region and possibility of taking vaginal and anal swabs if possible.
  • Re-examined victim after two weeks for exclude any venereal diseases and doing pregnancy test.

Study Type

Observational

Enrollment (Anticipated)

50

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

12 years and older (Child, Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Sampling Method

Non-Probability Sample

Study Population

As nature of a descriptive study design; All eligible cases of substance abuse admitted to Women Health Hospital and Safe Women's Unit belong to Assiut will be examined for inclusion and exclusion criteria. The cases will be included in the study in duration of one year (March 2022- February 2023).

Description

Inclusion Criteria:

  • All females above ≥ 12 years old with suspicious sexual violence or illegal pregnancy or criminal induction of abortion.

Exclusion Criteria:

  • All females who will present to the women's health hospital above 12 years old for ordinary medical advice or treatment of gynecologic or obstetric complaints

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Ecologic or Community
  • Time Perspectives: Prospective

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Measure the prevalence of sexual violence problem among females
Time Frame: from 1-6-2022 to 28-5-2023
These cases will be then analyzed in terms of Verifying legal procedures as careful reviewing of public prosecution order and associated victim's identification documents if present
from 1-6-2022 to 28-5-2023

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

July 1, 2022

Primary Completion (Anticipated)

May 28, 2023

Study Completion (Anticipated)

May 28, 2023

Study Registration Dates

First Submitted

March 21, 2022

First Submitted That Met QC Criteria

May 27, 2022

First Posted (Actual)

June 1, 2022

Study Record Updates

Last Update Posted (Actual)

June 22, 2022

Last Update Submitted That Met QC Criteria

June 19, 2022

Last Verified

June 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • a100

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Attempted Rape of Female

3
Subscribe